The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1387
ISSUE 1387
April 2, 2012
Issue 1387
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Low-Dose Sublingual Zolpidem (Intermezzo) for Insomnia due to Middle-of-the-Night Awakening
April 2, 2012 (Issue: 1387)
The FDA has approved a new low-dose sublingual
tablet formulation of the benzodiazepine receptor agonist
zolpidem tartrate (Intermezzo – Transcept/Purdue)
for treatment of insomnia due to middle-of-the-night
awakening. Ambien and other zolpidem...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.